247 related articles for article (PubMed ID: 34171437)
1. T-cell engager antibodies enable T cells to control HBV infection and to target HBsAg-positive hepatoma in mice.
Quitt O; Luo S; Meyer M; Xie Z; Golsaz-Shirazi F; Loffredo-Verde E; Festag J; Bockmann JH; Zhao L; Stadler D; Chou WM; Tedjokusumo R; Wettengel JM; Ko C; Noeßner E; Bulbuc N; Shokri F; Lüttgau S; Heikenwälder M; Bohne F; Moldenhauer G; Momburg F; Protzer U
J Hepatol; 2021 Nov; 75(5):1058-1071. PubMed ID: 34171437
[TBL] [Abstract][Full Text] [Related]
2. Activation of distinct antiviral T-cell immunity: A comparison of bi- and trispecific T-cell engager antibodies with a chimeric antigen receptor targeting HBV envelope proteins.
Debelec-Butuner B; Quitt O; Schreiber S; Momburg F; Wisskirchen K; Protzer U
Front Immunol; 2022; 13():1029214. PubMed ID: 36405686
[TBL] [Abstract][Full Text] [Related]
3. Immune-Mobilizing Monoclonal T Cell Receptors Mediate Specific and Rapid Elimination of Hepatitis B-Infected Cells.
Fergusson JR; Wallace Z; Connolly MM; Woon AP; Suckling RJ; Hine DW; Barber C; Bunjobpol W; Choi BS; Crespillo S; Dembek M; Dieckmann N; Donoso J; Godinho LF; Grant T; Howe D; McCully ML; Perot C; Sarkar A; Seifert FU; Singh PK; Stegmann KA; Turner B; Verma A; Walker A; Leonard S; Maini MK; Wiederhold K; Dorrell L; Simmons R; Knox A
Hepatology; 2020 Nov; 72(5):1528-1540. PubMed ID: 32770836
[TBL] [Abstract][Full Text] [Related]
4. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
[TBL] [Abstract][Full Text] [Related]
5. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
[TBL] [Abstract][Full Text] [Related]
6. Depletion of T cells
Klopp A; Schreiber S; Kosinska AD; Pulé M; Protzer U; Wisskirchen K
Front Immunol; 2021; 12():734246. PubMed ID: 34691041
[TBL] [Abstract][Full Text] [Related]
7. T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes.
Bohne F; Chmielewski M; Ebert G; Wiegmann K; Kürschner T; Schulze A; Urban S; Krönke M; Abken H; Protzer U
Gastroenterology; 2008 Jan; 134(1):239-47. PubMed ID: 18166356
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus immunopathogenesis.
Chisari FV; Ferrari C
Annu Rev Immunol; 1995; 13():29-60. PubMed ID: 7612225
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus envelope proteins can serve as therapeutic targets embedded in the host cell plasma membrane.
Zhao L; Chen F; Quitt O; Festag M; Ringelhan M; Wisskirchen K; Festag J; Yakovleva L; Sureau C; Bohne F; Aichler M; Bruss V; Shevtsov M; van de Klundert M; Momburg F; Möhl BS; Protzer U
Cell Microbiol; 2021 Dec; 23(12):e13399. PubMed ID: 34729894
[TBL] [Abstract][Full Text] [Related]
10. T cell recognition of hepatitis B and C viral antigens.
Jung MC; Diepolder HM; Pape GR
Eur J Clin Invest; 1994 Oct; 24(10):641-50. PubMed ID: 7531642
[TBL] [Abstract][Full Text] [Related]
11. Spatiotemporal Differences in Presentation of CD8 T Cell Epitopes during Hepatitis B Virus Infection.
Khakpoor A; Ni Y; Chen A; Ho ZZ; Oei V; Yang N; Giri R; Chow JX; Tan AT; Kennedy PT; Maini M; Urban S; Bertoletti A
J Virol; 2019 Feb; 93(4):. PubMed ID: 30518652
[TBL] [Abstract][Full Text] [Related]
12. T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice.
Krebs K; Böttinger N; Huang LR; Chmielewski M; Arzberger S; Gasteiger G; Jäger C; Schmitt E; Bohne F; Aichler M; Uckert W; Abken H; Heikenwalder M; Knolle P; Protzer U
Gastroenterology; 2013 Aug; 145(2):456-65. PubMed ID: 23639914
[TBL] [Abstract][Full Text] [Related]
13. CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cells.
Schreiber S; Dressler LS; Loffredo-Verde E; Asen T; Färber S; Wang W; Groll T; Chakraborty A; Kolbe F; Kreer C; Kosinska AD; Simon S; Urban S; Klein F; Riddell SR; Protzer U
Front Immunol; 2024; 15():1340619. PubMed ID: 38711498
[TBL] [Abstract][Full Text] [Related]
14. OX40 stimulation and PD-L1 blockade synergistically augment HBV-specific CD4 T cells in patients with HBeAg-negative infection.
Jacobi FJ; Wild K; Smits M; Zoldan K; Csernalabics B; Flecken T; Lang J; Ehrenmann P; Emmerich F; Hofmann M; Thimme R; Neumann-Haefelin C; Boettler T
J Hepatol; 2019 Jun; 70(6):1103-1113. PubMed ID: 30826436
[TBL] [Abstract][Full Text] [Related]
15. Immunopathogenesis of Hepatitis B Virus.
Tseng TC; Huang LR
J Infect Dis; 2017 Nov; 216(suppl_8):S765-S770. PubMed ID: 29156047
[TBL] [Abstract][Full Text] [Related]
16. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
[TBL] [Abstract][Full Text] [Related]
17. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
[TBL] [Abstract][Full Text] [Related]
18. Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use.
Wisskirchen K; Metzger K; Schreiber S; Asen T; Weigand L; Dargel C; Witter K; Kieback E; Sprinzl MF; Uckert W; Schiemann M; Busch DH; Krackhardt AM; Protzer U
PLoS One; 2017; 12(8):e0182936. PubMed ID: 28792537
[TBL] [Abstract][Full Text] [Related]
19. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins.
Safadi R; Israeli E; Papo O; Shibolet O; Melhem A; Bloch A; Rowe M; Alper R; Klein A; Hemed N; Segol O; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Am J Gastroenterol; 2003 Nov; 98(11):2505-15. PubMed ID: 14638356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
